Literature DB >> 21071325

$4 generics: How low, how broad, and why patient engagement is priceless.

N Lee Rucker1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21071325     DOI： 10.1331/JAPhA.2010.10546

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN： 1086-5802


× No keyword cloud information.
  6 in total

1.  Adding flexible temporal constraints to identify chronic comorbid conditions in ambulatory claims data.

Authors:  Walton Sumner; Dustin L Stwalley; Phillip V Asaro; Michael D Hagen; Margaret A Olsen
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

2.  Health expenditure comparison of extended-release metoprolol succinate and immediate-release metoprolol tartarate.

Authors:  Varun Vaidya; Pranav Patel
Journal:  Clinicoecon Outcomes Res       Date:  2012-02-07

3.  The Prevalence and Predictors of Low-Cost Generic Program Use in the Pediatric Population.

Authors:  Nathan James Pauly; Jeffery Charles Talbert; Joshua David Brown
Journal:  Drugs Real World Outcomes       Date:  2015-12-01

4.  Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.

Authors:  Nathan J Pauly; Jeffery C Talbert; Joshua Brown
Journal:  J Manag Care Spec Pharm       Date:  2016-06

5.  Empirical Assessment of the Impact of Low-Cost Generic Programs on Adherence-Based Quality Measures.

Authors:  Nathan J Pauly; Jeffery C Talbert; Joshua D Brown
Journal:  Pharmacy (Basel)       Date:  2017-03-08

6.  The Prevalence and Predictors of Low-Cost Generic Program Use in a Nationally Representative Uninsured Population.

Authors:  Joshua D Brown; Nathan J Pauly; Jeffery C Talbert
Journal:  Pharmacy (Basel)       Date:  2016-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.